S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.83 (+0.64%)
AAPL   178.68 (-1.15%)
MSFT   412.41 (-0.30%)
META   500.47 (+2.11%)
GOOGL   137.71 (-0.54%)
AMZN   177.03 (+0.15%)
TSLA   199.90 (-0.98%)
NVDA   807.88 (+2.12%)
NIO   5.75 (+0.00%)
AMD   200.15 (+3.96%)
BABA   74.55 (+0.70%)
T   17.00 (+0.41%)
F   12.62 (+1.45%)
MU   95.09 (+4.94%)
CGC   3.17 (-3.65%)
GE   158.49 (+1.02%)
DIS   111.89 (+0.28%)
AMC   4.36 (+0.93%)
PFE   26.61 (+0.19%)
PYPL   61.63 (+2.14%)
XOM   105.80 (+1.22%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.83 (+0.64%)
AAPL   178.68 (-1.15%)
MSFT   412.41 (-0.30%)
META   500.47 (+2.11%)
GOOGL   137.71 (-0.54%)
AMZN   177.03 (+0.15%)
TSLA   199.90 (-0.98%)
NVDA   807.88 (+2.12%)
NIO   5.75 (+0.00%)
AMD   200.15 (+3.96%)
BABA   74.55 (+0.70%)
T   17.00 (+0.41%)
F   12.62 (+1.45%)
MU   95.09 (+4.94%)
CGC   3.17 (-3.65%)
GE   158.49 (+1.02%)
DIS   111.89 (+0.28%)
AMC   4.36 (+0.93%)
PFE   26.61 (+0.19%)
PYPL   61.63 (+2.14%)
XOM   105.80 (+1.22%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.83 (+0.64%)
AAPL   178.68 (-1.15%)
MSFT   412.41 (-0.30%)
META   500.47 (+2.11%)
GOOGL   137.71 (-0.54%)
AMZN   177.03 (+0.15%)
TSLA   199.90 (-0.98%)
NVDA   807.88 (+2.12%)
NIO   5.75 (+0.00%)
AMD   200.15 (+3.96%)
BABA   74.55 (+0.70%)
T   17.00 (+0.41%)
F   12.62 (+1.45%)
MU   95.09 (+4.94%)
CGC   3.17 (-3.65%)
GE   158.49 (+1.02%)
DIS   111.89 (+0.28%)
AMC   4.36 (+0.93%)
PFE   26.61 (+0.19%)
PYPL   61.63 (+2.14%)
XOM   105.80 (+1.22%)
S&P 500   5,107.42 (+0.22%)
DOW   38,984.10 (-0.03%)
QQQ   441.83 (+0.64%)
AAPL   178.68 (-1.15%)
MSFT   412.41 (-0.30%)
META   500.47 (+2.11%)
GOOGL   137.71 (-0.54%)
AMZN   177.03 (+0.15%)
TSLA   199.90 (-0.98%)
NVDA   807.88 (+2.12%)
NIO   5.75 (+0.00%)
AMD   200.15 (+3.96%)
BABA   74.55 (+0.70%)
T   17.00 (+0.41%)
F   12.62 (+1.45%)
MU   95.09 (+4.94%)
CGC   3.17 (-3.65%)
GE   158.49 (+1.02%)
DIS   111.89 (+0.28%)
AMC   4.36 (+0.93%)
PFE   26.61 (+0.19%)
PYPL   61.63 (+2.14%)
XOM   105.80 (+1.22%)

Mind Medicine (MindMed) (MNMD) News Today

$5.86
+0.14 (+2.45%)
(As of 10:21 AM ET)
SourceHeadline
businesswire.com logoMindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
businesswire.com - March 1 at 9:00 AM
marketbeat.com logoQ1 2024 Earnings Estimate for Mind Medicine (MindMed) Inc. Issued By Roth Capital (NASDAQ:MNMD)
marketbeat.com - March 1 at 7:25 AM
MarketBeat logoFY2027 Earnings Estimate for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Issued By Roth Capital
americanbankingnews.com - March 1 at 4:26 AM
marketbeat.com logoRoth Capital Analysts Lower Earnings Estimates for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)
marketbeat.com - February 29 at 9:44 AM
businesswire.com logoMindMed Reports 2023 Financial Results and Business Updates
businesswire.com - February 28 at 7:05 AM
MarketBeat logoMind Medicine (MindMed) (MNMD) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - February 26 at 5:30 AM
finance.yahoo.com logoMindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
finance.yahoo.com - February 22 at 10:10 AM
businesswire.com logoMindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
businesswire.com - February 22 at 7:00 AM
MarketBeat logoMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - February 20 at 1:20 AM
marketbeat.com logoMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of "Buy" from Brokerages
marketbeat.com - February 20 at 1:20 AM
msn.com logoWhy Is MindMed (MNMD) Stock Up 8% Today?
msn.com - February 12 at 6:01 PM
msn.com logoElon Musk Says, 'If Drugs Helped My Productivity I'd Take Them' — This Psychedelic Bio-Tech Company Hopes To Help Build That Future
msn.com - February 6 at 8:12 AM
marketbeat.com logoMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts
marketbeat.com - January 26 at 2:59 AM
marketbeat.com logoAnalysts Offer Predictions for Mind Medicine (MindMed) Inc.'s Q1 2024 Earnings (NASDAQ:MNMD)
marketbeat.com - January 22 at 1:45 AM
msn.com logoMindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
msn.com - January 11 at 1:09 PM
marketbeat.com logoMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by Analysts
marketbeat.com - January 1 at 2:16 AM
marketbeat.com logoSchond L. Greenway Sells 5,652 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock
marketbeat.com - December 26 at 6:48 PM
msn.com logoMind Medicine (MNMD) Price Target Increased by 12.35% to 26.52
msn.com - December 16 at 5:16 PM
msn.com logoMindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder
msn.com - December 14 at 5:15 PM
msn.com logoGroundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
msn.com - December 14 at 5:15 PM
uk.finance.yahoo.com logoMind Medicine (MindMed) Inc. (MMQ.F)
uk.finance.yahoo.com - December 14 at 12:14 PM
marketbeat.com logo
marketbeat.com - December 14 at 7:28 AM
msn.com logoMindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved
msn.com - November 3 at 3:31 PM
finance.yahoo.com logoMindMed Reports Third Quarter 2023 Financial Results and Business Highlights
finance.yahoo.com - November 2 at 6:00 PM
seekingalpha.com logoMNMD Mind Medicine (MindMed) Inc.
seekingalpha.com - October 27 at 6:35 PM
msn.com logo7 Best Psychedelic Stocks to Watch
msn.com - October 26 at 2:27 PM
businesswire.com logoMindMed to Present Data on the Preclinical Activity of MM-402 at the 36 th Annual European College of Neuropsychopharmacology (ECNP) Congress
businesswire.com - October 3 at 11:17 PM
finance.yahoo.com logoMindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress
finance.yahoo.com - October 3 at 8:16 AM
finance.yahoo.com logoMindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
finance.yahoo.com - September 14 at 9:42 AM
finance.yahoo.com logoMindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
finance.yahoo.com - September 12 at 4:55 PM
finance.yahoo.com logoMindMed to Participate at September Investor Conferences
finance.yahoo.com - August 28 at 10:52 AM
finance.yahoo.com logoMindMed Secures $50.0 Million Credit Facility with K2 HealthVentures
finance.yahoo.com - August 14 at 8:00 AM
msn.com logoHC Wainwright & Co. Reiterates Mind Medicine (MNMD) Buy Recommendation
msn.com - August 4 at 9:03 PM
marketbeat.com logoMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Brokerages
marketbeat.com - August 4 at 2:42 PM
marketbeat.com logoMind Medicine (MindMed) (NASDAQ:MNMD) Earns Buy Rating from HC Wainwright
marketbeat.com - August 4 at 1:59 PM
finance.yahoo.com logoMindMed Reports Second Quarter 2023 Financial Results and Business Highlights
finance.yahoo.com - August 3 at 8:48 PM
finance.yahoo.com logoMindMed to Host Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Business Update
finance.yahoo.com - July 31 at 9:54 AM
msn.com logoRBC Capital Reiterates Mind Medicine (MNMD) Outperform Recommendation
msn.com - July 21 at 8:55 AM
finance.yahoo.com logoWe Think Mind Medicine (MindMed) (NASDAQ:MNMD) Can Afford To Drive Business Growth
finance.yahoo.com - July 14 at 4:20 PM
markets.businessinsider.com logoThe Latest Analyst Ratings for Mind Medicine
markets.businessinsider.com - June 28 at 11:50 PM
finance.yahoo.com logoMindMed to Participate in the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
finance.yahoo.com - June 22 at 10:18 AM
finance.yahoo.com logoFCM Received Significant Support from Shareholders, Disappointed that “Passive” Investors Saw Fit to Give Incumbent Directors Another Chance to Disappoint
finance.yahoo.com - June 22 at 10:18 AM
finance.yahoo.com logoMindMed Announces Election of All Six Company Nominees at Annual Meeting
finance.yahoo.com - June 21 at 12:35 PM
finance.yahoo.com logoMindMed Provides Overview of Clinical Progress and Corporate Updates at Investor Day
finance.yahoo.com - June 20 at 10:42 AM
finance.yahoo.com logoFCM Denounces MindMed’s Manipulation of Corporate Machinery to Protect Incumbent Board of Directors
finance.yahoo.com - June 15 at 6:20 PM
finance.yahoo.com logoMindMed Adjourns Annual General Meeting of Shareholders
finance.yahoo.com - June 15 at 1:20 PM
finance.yahoo.com logoFCM Calls for Socially Responsible Investors to Vote for Change at MindMed
finance.yahoo.com - June 9 at 5:07 PM
finance.yahoo.com logoMindMed Urges Shareholders to Vote TODAY for Company Nominees Ahead of June 13th Deadline
finance.yahoo.com - June 9 at 5:07 PM
finance.yahoo.com logoLeading Proxy Advisory Firm Glass Lewis Recommends MindMed Shareholders Vote FOR All Six Company Nominees
finance.yahoo.com - June 8 at 5:32 PM
msn.com logoMindMed shareholder FCM pushing for speedier development of lead drug
msn.com - June 7 at 12:40 PM
Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.



MNMD Media Mentions By Week

MNMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MNMD
News Sentiment

0.13

0.61

Average
Medical
News Sentiment

MNMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MNMD Articles
This Week

12

1

MNMD Articles
Average Week

Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MNMD) was last updated on 3/1/2024 by MarketBeat.com Staff